MEDX.SW medmix AG SIX down 16.26% intraday 27 Feb 2026: watch CHF 9.44 support

MEDX.SW stock plunged 16.26% intraday to CHF 9.53 on 27 Feb 2026 after Medmix published FY-2025 results that mixed weaker revenue with better margins. The move made medmix AG (SIX: MEDX.SW) one of Switzerland’s top losers during the session, with volume at 82,374 shares versus a 3-month average of 91,914. Investors reacted to a 7.4% revenue decline paired with a 90 basis-point margin improvement, while EPS remains negative at -0.14. We break down the earnings, valuation, technicals, Meyka AI grading, and where short-term support and targets sit.